We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Longitudinal Heart Stress Assessment Improves Prediction of Cardiovascular Outcomes

By LabMedica International staff writers
Posted on 20 Aug 2026

Accurately predicting cardiovascular disease (CVD) risk in older adults is challenging when assessments rely on single, point-in-time biomarker measurements. More...

Dynamic indicators that reflect evolving cardiac stress could better identify individuals at heightened risk. Serial testing of N-terminal pro-B-type natriuretic peptide (NT-proBNP) offers a way to track heart stress over time. A new study shows that longitudinal changes in this marker may improve CVD and mortality risk stratification in community-dwelling older adults.

Southern Medical University (Guangzhou, China) investigators evaluated a “heart stress (HS) status” metric derived from three-year changes in NT-proBNP. NT-proBNP was measured at trial enrollment and again at year 3, and participants were categorized as persistently HS-free, HS remission, incident HS, or sustained HS. The analysis tested whether these serial, biomarker-defined states aligned with subsequent cardiovascular disease (CVD) events and all-cause mortality.

The cohort included 8,454 community-dwelling older adults without prior CVD. Over a median follow-up of 8.0 years, researchers recorded 818 CVD events and 1,584 deaths. Risk estimates were summarized as adjusted absolute risks at year 8.

Compared with the persistently HS-free group, adjusted absolute risk for total CVD rose by 7.4% among those with incident HS and by 6.7% among those with sustained HS at year 8. For all-cause mortality, adjusted absolute risks increased by 6.1% and 7.5% for the incident HS and sustained HS categories, respectively. The HS remission category showed adjusted absolute risks similar to those in the persistently HS-free group.

The findings were published online on August 18, 2026, in Annals of Internal Medicine. The authors indicated that additional research is needed to determine whether HS status based on serial NT-proBNP values can guide care to reduce CVD and mortality risk in older adults.

“Future studies should determine whether HS status based on serial values of NT-proBNP can inform care to reduce CVD and mortality risk in an older adult population,” the authors write.

Related Links
Southern Medical University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.